|
The BYU silver study documents the results of a quality
colloidal silver product compared to standard antibiotics, as used
against a wide range of illness-causing organisms. The study conclusively
demonstrated that based on the in-vitro studies conducted, colloidal
silver may be an effective antibiotic alternative.
Unsponsored BYU Laboratory Studies Conducted by Dr. Ron W. Leavitt
Professor of Microbiology at Brigham Young University
Product: ASAP between
1.25 - 5 PPM, Isolated Colloidal Silver
Studies Indicate that ASAP May
Be an Effective Antibiotic Alternative According to Dr. Ron Leavitt of BYU University,
as reported by Deseret
News, Tuesday, May 16, 2000, a quality colloidal silver may serve
as a suitable antibiotic alternative. Lois
Collins of Deseret News quotes Dr. Leavitt as writing "The
data suggests that with the low toxicity associated with colloidal
silver, in general, and the broad spectrum of antimicrobial activity
of this colloidal silver preparation, this preparation may be effectively
used as an alternative to antibiotics." The original study tested ASAP colloidal silver against
tetracyclines, fluorinated quinolones (Ofloxacin), the penicillins,
the cephalosporins (Cefaperazone) and the macrolides (Erythromycin).
Among the microbes tested were streptococcuses, pneumonia, E. coli,
salmonella, and shigella. AM Silver has removed the original study data from
their website. However, you can still view references to the studies
on their site: Click here. Lois Collins also quoted Ron Leavitt as stating, "When
one of my research assistants suggested that we check this out, I
was real skeptical of something that sounded a lot like snake oil.
I said we'd do it if they would pay for the supplies. But whatever
the data is, it is. We agreed there would be no restriction on publication
of the data." Although Dr. Leavitt stated that there would be no
restriction on the publication of data, apparently Brigham Young
University disagrees. In a letter dated July 23, 2002, the assistant
to general counsel for BYU, stated: "Any studies that occured at BYU were not intended
for dissemenation to the general public." In what can almost be construed as a blanket attack
against first ammendment rights, BYU has been sending intimidating
cease and desist orders out to individuals and organizations referencing
the study. These letters not only pursue the reasonable demand that
copyrights be respected, but further demand that BYU not be mentioned
in conjunction with the study at all, despite the fact this information
now exists in the public domain. Further, attached to these letters is an official BYU
position statement, where the antimicrobial effects of colloidal
silver are compared to bleach. While it is clear ( in fact, self
evident ) that studies done in-vitro cannot be applied to a clinical
situation, comparing colloidal silver to bleach can only be regarded
as a very distasteful disinformation tactic. While the sarcasm of
the comment is not lost in the statement, the undiluted truth is.
As the quote by Dr. Ron Leavitt above indicates, colloidal silver
has a low level of toxicity ( see our pages on silver
toxicity for details ). The Colloidal Silver Database Website's position is
that we are not in violation of copyright laws in this matter. Furthermore,
we believe that the general public has a right to know the facts
associated with the controversy, insofar as doing so does not infringe
upon the rights of the parties in question, as a part of our journalistic
expression.
All
Content Copyright 2007 AVRA unless otherwise specified content
copyright 2007 AVRA and managed by -
Free Las Vegas Website Hosting
 back
to top 
Silver
Colloidal Silver
Colloidal
Silver Science & Research Center
Colloidal
Silver & the
University of North Texas ---- Colloidal
Silver BYU Study ----Bentonite
and Silver Comparison Study ---- Cansema,
Silver, Healing Clay, and Skin Cancer ---- Dr.
Robert O Becker ----Silver
Iontophoresis ----Attributes
of Silver Particles and Silver Solutions
|
